<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34209705</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2079-9721</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>29</Day></PubDate></JournalIssue><Title>Diseases (Basel, Switzerland)</Title><ISOAbbreviation>Diseases</ISOAbbreviation></Journal><ArticleTitle>COVID-19-Associated Cardiovascular Complications.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">47</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diseases9030047</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) has been reported to cause cardiovascular complications such as myocardial injury, thromboembolic events, arrhythmia, and heart failure. Multiple mechanisms-some overlapping, notably the role of inflammation and IL-6-potentially underlie these complications. The reported cardiac injury may be a result of direct viral invasion of cardiomyocytes with consequent unopposed effects of angiotensin II, increased metabolic demand, immune activation, or microvascular dysfunction. Thromboembolic events have been widely reported in both the venous and arterial systems that have attracted intense interest in the underlying mechanisms. These could potentially be due to endothelial dysfunction secondary to direct viral invasion or inflammation. Additionally, thromboembolic events may also be a consequence of an attempt by the immune system to contain the infection through immunothrombosis and neutrophil extracellular traps. Cardiac arrhythmias have also been reported with a wide range of implicated contributory factors, ranging from direct viral myocardial injury, as well as other factors, including at-risk individuals with underlying inherited arrhythmia syndromes. Heart failure may also occur as a progression from cardiac injury, precipitation secondary to the initiation or withdrawal of certain drugs, or the accumulation of des-Arg<sup>9</sup>-bradykinin (DABK) with excessive induction of pro-inflammatory G protein coupled receptor B<sub>1</sub> (BK1). The presenting cardiovascular symptoms include chest pain, dyspnoea, and palpitations. There is currently intense interest in vaccine-induced thrombosis and in the treatment of Long COVID since many patients who have survived COVID-19 describe persisting health problems. This review will summarise the proposed physiological mechanisms of COVID-19-associated cardiovascular complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Clement C E</ForeName><Initials>CCE</Initials><AffiliationInfo><Affiliation>Division of Molecular &amp; Clinical Medicine, School of Medicine, Ninewells Hospital &amp; Medical School, University of Dundee, Dundee DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Kashan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Molecular &amp; Clinical Medicine, School of Medicine, Ninewells Hospital &amp; Medical School, University of Dundee, Dundee DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Connell</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Molecular &amp; Clinical Medicine, School of Medicine, Ninewells Hospital &amp; Medical School, University of Dundee, Dundee DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mordi</LastName><ForeName>Ify R</ForeName><Initials>IR</Initials><Identifier Source="ORCID">0000-0002-2686-729X</Identifier><AffiliationInfo><Affiliation>Division of Molecular &amp; Clinical Medicine, School of Medicine, Ninewells Hospital &amp; Medical School, University of Dundee, Dundee DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>George</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8154-8278</Identifier><AffiliationInfo><Affiliation>Division of Molecular &amp; Clinical Medicine, School of Medicine, Ninewells Hospital &amp; Medical School, University of Dundee, Dundee DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lang</LastName><ForeName>Elizabeth Msl</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Division of Molecular &amp; Clinical Medicine, School of Medicine, Ninewells Hospital &amp; Medical School, University of Dundee, Dundee DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lang</LastName><ForeName>Chim C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Division of Molecular &amp; Clinical Medicine, School of Medicine, Ninewells Hospital &amp; Medical School, University of Dundee, Dundee DD1 9SY, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diseases</MedlineTA><NlmUniqueID>101636232</NlmUniqueID><ISSNLinking>2079-9721</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cardiovascular system</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>2</Day><Hour>1</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34209705</ArticleId><ArticleId IdType="pmc">PMC8293160</ArticleId><ArticleId IdType="doi">10.3390/diseases9030047</ArticleId><ArticleId IdType="pii">diseases9030047</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guzik T.J., Mohiddin S.A., DiMarco A., Patel V., Savvatis K., Marelli-Berg F.M., Madhur M.S., Tomaszewski M., Maffia P., D&#x2019;Acquisto F., et al. COVID-19 and the cardiovascular system: Implications for risk assessment, diagnosis, and treatment options. Cardiovasc. Res. 2020;116:1666&#x2013;1687. doi: 10.1093/cvr/cvaa106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa106</ArticleId><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Coronavirus Disease 2019 (COVID-19) Situation Report&#x2014;51.  [(accessed on 28 January 2021)];2020  Available online:  https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10.</Citation></Reference><Reference><Citation>World Health Organization  Weekly Epidemiological Update&#x2014;29 December 2020.  [(accessed on 28 January 2021)];2020  Available online:  https://www.who.int/publications/m/item/weekly-epidemiological-update---29-december-2020.</Citation></Reference><Reference><Citation>Astuti I. Ysrafil Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab. Syndr. Clin. Res. Rev. 2020;14:407&#x2013;412. doi: 10.1016/j.dsx.2020.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.04.020</ArticleId><ArticleId IdType="pmc">PMC7165108</ArticleId><ArticleId IdType="pubmed">32335367</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.-Z., Holmes E.C. A Genomic Perspective on the Origin and Emergence of SARS-CoV-2. Cell. 2020;181:223&#x2013;227. doi: 10.1016/j.cell.2020.03.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.03.035</ArticleId><ArticleId IdType="pmc">PMC7194821</ArticleId><ArticleId IdType="pubmed">32220310</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology Working Group for NCIP Epidemic Response. Chinese Center for Disease Control and Prevention The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41:145&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pubmed">32064853</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Driggin E., Madhavan M.V., Bikdeli B., Chuich T., Laracy J., Biondi-Zoccai G., Brown T.S., Der-Nigoghossian C., Zidar D.A., Haythe J., et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J. Am. Coll. Cardiol. 2020;75:2352&#x2013;2371. doi: 10.1016/j.jacc.2020.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7198856</ArticleId><ArticleId IdType="pubmed">32201335</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S., Chen S., Li X., Liu S., Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18:1421&#x2013;1424. doi: 10.1111/jth.14830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14830</ArticleId><ArticleId IdType="pmc">PMC7262324</ArticleId><ArticleId IdType="pubmed">32271988</ArticleId></ArticleIdList></Reference><Reference><Citation>Lala A., Johnson K., Januzzi J.L., Russak A.J., Paranjpe I., Richter F., Zhao S., Somani S., Van Vleck T., Vaid A., et al. Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection. J. Am. Coll. Cardiol. 2020;76:533&#x2013;546. doi: 10.1016/j.jacc.2020.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.007</ArticleId><ArticleId IdType="pmc">PMC7279721</ArticleId><ArticleId IdType="pubmed">32517963</ArticleId></ArticleIdList></Reference><Reference><Citation>Cammann V.L., Szawan K.A., D&#x2019;Ascenzo F., Gili S., Dreiding S., W&#xfc;rdinger M., Manka R., St&#xe4;hli B.E., Holy E.W., Siegrist P., et al. Outcomes of acute coronary syndromes in coronavirus disease 2019. Clin. Res. Cardiol. Off. J. Ger. Card. Soc. 2020;109:1601&#x2013;1604. doi: 10.1007/s00392-020-01742-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01742-6</ArticleId><ArticleId IdType="pmc">PMC7501997</ArticleId><ArticleId IdType="pubmed">32951095</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Lax S.F., Skok K., Zechner P., Kessler H.H., Kaufmann N., Koelblinger C., Vander K., Bargfrieder U., Trauner M. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results from a Prospective, Single-Center, Clinicopathologic Case Series. Ann. Intern. Med. 2020;173:350&#x2013;361. doi: 10.7326/M20-2566.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-2566</ArticleId><ArticleId IdType="pmc">PMC7249507</ArticleId><ArticleId IdType="pubmed">32422076</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell C., Kahwash R. Will Complement Inhibition Be the New Target in Treating COVID-19&#x2013;Related Systemic Thrombosis? Circulation. 2020;141:1739&#x2013;1741. doi: 10.1161/CIRCULATIONAHA.120.047419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047419</ArticleId><ArticleId IdType="pubmed">32271624</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Tacquard C., Severac F., Leonard-Lorant I., Ohana M., Delabranche X., Merdji H., Clere-Jehl R., Schenck M., Gandet F.F., et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med. 2020;46:1089&#x2013;1098. doi: 10.1007/s00134-020-06062-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06062-x</ArticleId><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference><Reference><Citation>Middeldorp S., Coppens M., Van Haaps T.F., Foppen M., Vlaar A.P., M&#xfc;ller M.C.A., Bouman C.C.S., Beenen L.F.M., Kootte R.S., Heijmans J., et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J. Thromb. Haemost. 2020;18:1995&#x2013;2002. doi: 10.1111/jth.14888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14888</ArticleId><ArticleId IdType="pmc">PMC7497052</ArticleId><ArticleId IdType="pubmed">32369666</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann D. Autopsy Findings and Venous Thromboembolism in Patients with COVID-19. Ann. Intern. Med. 2020;173:1030. doi: 10.7326/L20-1206.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/L20-1206</ArticleId><ArticleId IdType="pubmed">33316197</ArticleId></ArticleIdList></Reference><Reference><Citation>Malas M.B., Naazie I.N., Elsayed N., Mathlouthi A., Marmor R., Clary B. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis. EClinicalMedicine. 2020;29&#x2013;30:100639. doi: 10.1016/j.eclinm.2020.100639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100639</ArticleId><ArticleId IdType="pmc">PMC7679115</ArticleId><ArticleId IdType="pubmed">33251499</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K., Alpert J.S., Jaffe A.S., Chaitman B.R., Bax J.J., Morrow D.A., White H.D., ESC Scientific Document Group Fourth universal definition of myocardial infarction. Eur. Heart J. 2018;40:237&#x2013;269. doi: 10.1093/eurheartj/ehy462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy462</ArticleId><ArticleId IdType="pubmed">30165617</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P.P., Blet A., Smyth D., Li H. The Science Underlying COVID-19: Implications for the Cardiovascular System. Circulation. 2020;142:68&#x2013;78. doi: 10.1161/CIRCULATIONAHA.120.047549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047549</ArticleId><ArticleId IdType="pubmed">32293910</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S., Qin M., Shen B., Cai Y., Liu T., Yang F., Gong W., Liu X., Liang J., Zhao Q., et al. Association of Cardiac Injury with Mortality in Hospitalized Patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802. doi: 10.1001/jamacardio.2020.0950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T., Fan Y., Chen M., Wu X., Zhang L., He T., Wang H., Wan J., Wang X., Lu Z. Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:811&#x2013;818. doi: 10.1001/jamacardio.2020.1017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangalore S., Sharma A., Slotwiner A., Yatskar L., Harari R., Shah B., Ibrahim H., Friedman G.H., Thompson C., Alviar C.L., et al. ST-Segment Elevation in Patients with Covid-19&#x2014;A Case Series. N. Engl. J. Med. 2020;382:2478&#x2013;2480. doi: 10.1056/NEJMc2009020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009020</ArticleId><ArticleId IdType="pmc">PMC7182015</ArticleId><ArticleId IdType="pubmed">32302081</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanini G.G., Montorfano M., Trabattoni D., Andreini D., Ferrante G., Ancona M., Metra M., Curello S., Maffeo D., Pero G., et al. ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes. Circulation. 2020;141:2113&#x2013;2116. doi: 10.1161/CIRCULATIONAHA.120.047525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047525</ArticleId><ArticleId IdType="pmc">PMC7302062</ArticleId><ArticleId IdType="pubmed">32352306</ArticleId></ArticleIdList></Reference><Reference><Citation>Boukhris M., Hillani A., Moroni F., Annabi M.S., Addad F., Ribeiro M.H., Mansour S., Zhao X., Ybarra L.F., Abbate A., et al. Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective. Can. J. Cardiol. 2020;36:1068&#x2013;1080. doi: 10.1016/j.cjca.2020.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2020.05.018</ArticleId><ArticleId IdType="pmc">PMC7229739</ArticleId><ArticleId IdType="pubmed">32425328</ArticleId></ArticleIdList></Reference><Reference><Citation>Turagam M.K., Musikantow D., Goldman M.E., Bassily-Marcus A., Chu E., Shivamurthy P., Lampert J., Kawamura I., Bokhari M., Whang W., et al. Malignant Arrhythmias in Patients with COVID-19: Incidence, Mechanisms, and Outcomes. Circ. Arrhythmia Electrophysiol. 2020;13:e008920. doi: 10.1161/CIRCEP.120.008920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.120.008920</ArticleId><ArticleId IdType="pmc">PMC7668347</ArticleId><ArticleId IdType="pubmed">33026892</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao S.-C., Shao S.-C., Cheng C.-W., Chen Y.-C., Hung M.-J. Incidence rate and clinical impacts of arrhythmia following COVID-19: A systematic review and meta-analysis of 17,435 patients. Crit. Care. 2020;24:1&#x2013;7. doi: 10.1186/s13054-020-03368-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03368-6</ArticleId><ArticleId IdType="pmc">PMC7727094</ArticleId><ArticleId IdType="pubmed">33302973</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Wu D., Chen H., Yan W., Yang D., Chen G., Ma K., Xu D., Yu H., Wang H., et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ. 2020;368:m1091. doi: 10.1136/bmj.m1091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1091</ArticleId><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Coats A.J.S., Zheng Z., Adamo M., Ambrosio G., Anker S.D., Butler J., Xu D., Mao J., Khan M.S., et al. Management of heart failure patients withCOVID-19: A joint position paper of the Chinese Heart Failure Association &amp; National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2020;22:941&#x2013;956. doi: 10.1002/ejhf.1915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1915</ArticleId><ArticleId IdType="pubmed">32463543</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey J.R., Caro-Cod&#xf3;n J., Rosillo S.O., Iniesta &#xc1;.M., Castrej&#xf3;n-Castrej&#xf3;n S., Marco-Clement I., Mart&#xed;n-Polo L., Merino-Argos C., Rodr&#xed;guez-Sotelo L., Garc&#xed;a-Veas J.M., et al. Heart failure in COVID-19 patients: Prevalence, incidence and prognostic implications. Eur. J. Heart Failure. 2020 doi: 10.1002/ejhf.1990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1990</ArticleId><ArticleId IdType="pmc">PMC7461427</ArticleId><ArticleId IdType="pubmed">32833283</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattar N., Ho F.K., Gill J.M., Ghouri N., Gray S., Celis-Morales C.A., Katikireddi S.V., Berry C., Pell J.P., McMurray J.J., et al. BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: Preliminary findings from UK biobank. Diabetes Metab. Syndr. Clin. Res. Rev. 2020;14:1149&#x2013;1151. doi: 10.1016/j.dsx.2020.06.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.06.060</ArticleId><ArticleId IdType="pmc">PMC7326434</ArticleId><ArticleId IdType="pubmed">32668401</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty A.B., Harrison E.M., Green C.A., Hardwick H.E., Pius R., Norman L., Holden K.A., Read J.M., Dondelinger F., Carson G., et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Prospective observational cohort study. BMJ. 2020;369:m1985. doi: 10.1136/bmj.m1985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1985</ArticleId><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaduganathan M., Vardeny O., Michel T., McMurray J.J.V., Pfeffer M.A., Solomon S.D. Renin&#x2013;Angiotensin&#x2013;Aldosterone System Inhibitors in Patients with Covid-19. N. Engl. J. Med. 2020;382:1653&#x2013;1659. doi: 10.1056/NEJMsr2005760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsr2005760</ArticleId><ArticleId IdType="pmc">PMC7121452</ArticleId><ArticleId IdType="pubmed">32227760</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimes J.M., Grimes K.V. p38 MAPK Inhibition: A Promising Therapeutic Approach for COVID-19. J. Mol. Cell. Cardiol. 2020;144:63&#x2013;65. doi: 10.1016/j.yjmcc.2020.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2020.05.007</ArticleId><ArticleId IdType="pmc">PMC7228886</ArticleId><ArticleId IdType="pubmed">32422320</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia H.P., Look D.C., Shi L., Hickey M., Pewe L., Netland J., Farzan M., Wohlford-Lenane C., Perlman S., McCray P.B. ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia. J. Virol. 2005;79:14614&#x2013;14621. doi: 10.1128/JVI.79.23.14614-14621.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.23.14614-14621.2005</ArticleId><ArticleId IdType="pmc">PMC1287568</ArticleId><ArticleId IdType="pubmed">16282461</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein: Cell. Cell. 2020;181:281&#x2013;292. doi: 10.1016/j.cell.2020.02.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.058</ArticleId><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavazzi G., Pellegrini C., Maurelli M., Belliato M., Sciutti F., Bottazzi A., Sepe P.A., Resasco T., Camporotondo R., Bruno R., et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur. J. Heart Fail. 2020;22:911&#x2013;915. doi: 10.1002/ejhf.1828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1828</ArticleId><ArticleId IdType="pmc">PMC7262276</ArticleId><ArticleId IdType="pubmed">32275347</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Li X., Chen M., Feng Y., Xiong C. The ACE2 Expression in Human Heart Indicates New Potential Mechanism of Heart Injury Among Patients Infected with SARS-CoV-2. Cardiovasc. Res. 2020;116:1097&#x2013;1100. doi: 10.1093/cvr/cvaa078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa078</ArticleId><ArticleId IdType="pmc">PMC7184507</ArticleId><ArticleId IdType="pubmed">32227090</ArticleId></ArticleIdList></Reference><Reference><Citation>Leisman D., Deutschman C.S., Legrand M. Facing COVID-19 in the ICU: Vascular dysfunction, thrombosis, and dysregulated inflammation. Intensiv. Care Med. 2020;46:1105&#x2013;1108. doi: 10.1007/s00134-020-06059-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06059-6</ArticleId><ArticleId IdType="pmc">PMC7186535</ArticleId><ArticleId IdType="pubmed">32347323</ArticleId></ArticleIdList></Reference><Reference><Citation>Jecko T., Alok S. SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism? Semin. Thromb. Hemost. 2020;46:777&#x2013;780.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7645824</ArticleId><ArticleId IdType="pubmed">32396963</ArticleId></ArticleIdList></Reference><Reference><Citation>Violi F., Pastori D., Pignatelli P., Cangemi R. SARS-CoV-2 and Myocardial Injury: A Role for Nox2? Intern. Emerg. Med. 2020;15:755&#x2013;758. doi: 10.1007/s11739-020-02348-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-020-02348-6</ArticleId><ArticleId IdType="pmc">PMC7214847</ArticleId><ArticleId IdType="pubmed">32399954</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolau L., Magalh&#xe3;es P.J., Vale M.L. What would S&#xe9;rgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system? Med. Hypotheses. 2020;143:109886. doi: 10.1016/j.mehy.2020.109886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109886</ArticleId><ArticleId IdType="pmc">PMC7261103</ArticleId><ArticleId IdType="pubmed">32504925</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannis D., Ziogas I.A., Gianni P. Coagulation Disorders in Coronavirus Infected Patients: COVID-19, SARS-CoV-1, MERS-CoV and Lessons from the Past. J. Clin. Virol. 2020;127:104362. doi: 10.1016/j.jcv.2020.104362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104362</ArticleId><ArticleId IdType="pmc">PMC7195278</ArticleId><ArticleId IdType="pubmed">32305883</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P., L&#xfc;scher T. COVID-19 is, in the end, an endothelial disease. Eur. Heart J. 2020;41:3038&#x2013;3044. doi: 10.1093/eurheartj/ehaa623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa623</ArticleId><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C., Gambardella J., Morelli M.B., Wang X., Marfella R., Santulli G. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence. J. Clin. Med. 2020;9:1417. doi: 10.3390/jcm9051417.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9051417</ArticleId><ArticleId IdType="pmc">PMC7290769</ArticleId><ArticleId IdType="pubmed">32403217</ArticleId></ArticleIdList></Reference><Reference><Citation>Panigada M., Bottino N., Tagliabue P., Grasselli G., Novembrino C., Chantarangkul V., Pesenti A., Peyvandi F., Tripodi A. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J. Thromb. Haemost. 2020;18:1738&#x2013;1742. doi: 10.1111/jth.14850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14850</ArticleId><ArticleId IdType="pmc">PMC9906150</ArticleId><ArticleId IdType="pubmed">32302438</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Zuo M., Yalavarthi S., Gockman K., Madison J.A., Shi H., Woodard W., Lezak S.P., Lugogo N.L., Knight J.S., et al. Neutrophil extracellular traps and thrombosis in COVID-19. J. Thromb. Thrombolysis. 2020;51:446&#x2013;453. doi: 10.1007/s11239-020-02324-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02324-z</ArticleId><ArticleId IdType="pmc">PMC7642240</ArticleId><ArticleId IdType="pubmed">33151461</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco A., Coronado M.-J., Hern&#xe1;ndez-Terciado F., Mart&#xed;n P., Royuela A., Ramil E., Garc&#xed;a D., Goicolea J., Del Trigo M., Ortega J., et al. Assessment of Neutrophil Extracellular Traps in Coronary Thrombus of a Case Series of Patients with COVID-19 and Myocardial Infarction. JAMA Cardiol. 2021;6:469. doi: 10.1001/jamacardio.2020.7308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.7308</ArticleId><ArticleId IdType="pmc">PMC7772744</ArticleId><ArticleId IdType="pubmed">33372956</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong T.-Y., Redwood S., Prendergast B., Chen M. Coronaviruses and the cardiovascular system: Acute and long-term implications. Eur. Heart J. 2020;41:1798&#x2013;1800. doi: 10.1093/eurheartj/ehaa231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa231</ArticleId><ArticleId IdType="pmc">PMC7454513</ArticleId><ArticleId IdType="pubmed">32186331</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y.Y., Ma Y.T., Zhang J.Y., Xie X. COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. 2020;17:259&#x2013;260. doi: 10.1038/s41569-020-0360-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0360-5</ArticleId><ArticleId IdType="pmc">PMC7095524</ArticleId><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini P.E., Boutjdir M., Capecchi P. COVID-19, Arrhythmic Risk and Inflammation: Mind the Gap! Circulation. 2020;142:7&#x2013;9. doi: 10.1161/CIRCULATIONAHA.120.047293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047293</ArticleId><ArticleId IdType="pubmed">32286863</ArticleId></ArticleIdList></Reference><Reference><Citation>McElvaney O.J., Curley G.F., Rose-John S., McElvaney N.G. Interleukin-6: Obstacles to targeting a complex cytokine in critical illness. Lancet Respir. Med. 2021;9:643&#x2013;654. doi: 10.1016/S2213-2600(21)00103-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00103-X</ArticleId><ArticleId IdType="pmc">PMC8051931</ArticleId><ArticleId IdType="pubmed">33872590</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin E.J., Longo D.L., Baden L.R. Interleukin-6 Receptor Inhibition in Covid-19&#x2014;Cooling the Inflammatory Soup. N. Engl. J. Med. 2021;384:1564&#x2013;1565. doi: 10.1056/NEJMe2103108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2103108</ArticleId><ArticleId IdType="pmc">PMC7944949</ArticleId><ArticleId IdType="pubmed">33631064</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Yalavarthi S., Shi H., Gockman K., Zuo M., Madison J.A., Blair C., Weber A., Barnes B.J., Egeblad M., et al. Neutrophil Extracellular Traps (NETs) as Markers of Disease Severity in COVID-19 [Preprint] medRxiv. 2020 doi: 10.1101/2020.04.09.20059626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.09.20059626</ArticleId><ArticleId IdType="pmc">PMC7308057</ArticleId><ArticleId IdType="pubmed">32329756</ArticleId></ArticleIdList></Reference><Reference><Citation>Siripanthong B., Nazarian S., Muser D., Deo R., Santangeli P., Khanji M.Y., Cooper L.T., Chahal C.A.A. Recognizing COVID-19&#x2013;related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17:1463&#x2013;1471. doi: 10.1016/j.hrthm.2020.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.05.001</ArticleId><ArticleId IdType="pmc">PMC7199677</ArticleId><ArticleId IdType="pubmed">32387246</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipriani A., Zorzi A., Ceccato D., Capone F., Parolin M., Donato F., Fioretto P., Pesavento R., Previato L., Maffei P., et al. Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin. Int. J. Cardiol. 2020;316:280&#x2013;284. doi: 10.1016/j.ijcard.2020.05.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2020.05.036</ArticleId><ArticleId IdType="pmc">PMC7235573</ArticleId><ArticleId IdType="pubmed">32439366</ArticleId></ArticleIdList></Reference><Reference><Citation>Belhadjer Z., M&#xe9;ot M., Bajolle F., Khraiche D., Legendre A., Abakka S., Auriau J., Grimaud M., Oualha M., Beghetti M., et al. Acute Heart Failure in Multisystem Inflammatory Syndrome in Children (MIS-C) in the Context of Global SARS-CoV-2 Pandemic. Circulation. 2020;142:429&#x2013;436. doi: 10.1161/CIRCULATIONAHA.120.048360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.048360</ArticleId><ArticleId IdType="pubmed">32418446</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA&#x2014;U.S  Food &amp; Drug Administration. FDA Approves First Treatment for COVID-19.  [(accessed on 11 May 2021)];2020  Available online:  https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid-19.</Citation></Reference><Reference><Citation>Giudicessi J.R., Noseworthy P.A., Friedman P.A., Ackerman M.J. Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19) Mayo Clin. Proc. 2020;95:1213&#x2013;1221. doi: 10.1016/j.mayocp.2020.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.03.024</ArticleId><ArticleId IdType="pmc">PMC7141471</ArticleId><ArticleId IdType="pubmed">32359771</ArticleId></ArticleIdList></Reference><Reference><Citation>Younis N.K., Zareef R.O., Al Hassan S.N., Bitar F., Eid A.H., Arabi M. Hydroxychloroquine in COVID-19 Patients: Pros and Cons. Front. Pharmacol. 2020;11:597985. doi: 10.3389/fphar.2020.597985.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.597985</ArticleId><ArticleId IdType="pmc">PMC7751757</ArticleId><ArticleId IdType="pubmed">33364965</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankelson L., Karam G., Becker M.L., Chinitz L.A., Tsai M.-C. QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review. Heart Rhythm. 2020;17:1472&#x2013;1479. doi: 10.1016/j.hrthm.2020.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.05.008</ArticleId><ArticleId IdType="pmc">PMC7211688</ArticleId><ArticleId IdType="pubmed">32438018</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercuro N.J., Yen C.F., Shim D.J., Maher T.R., McCoy C.M., Zimetbaum P.J., Gold H.S. Risk of QT Interval Prolongation Associated with Use of Hydroxychloroquine with or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1036&#x2013;1041. doi: 10.1001/jamacardio.2020.1834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1834</ArticleId><ArticleId IdType="pmc">PMC7195692</ArticleId><ArticleId IdType="pubmed">32936252</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal G., Henry B.M., Aggarwal S., Bangalore S. Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019. Am. J. Cardiol. 2020;128:147&#x2013;150. doi: 10.1016/j.amjcard.2020.04.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2020.04.054</ArticleId><ArticleId IdType="pmc">PMC7228893</ArticleId><ArticleId IdType="pubmed">32425199</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastick K.A., Okafor E.C., Wang F., Lofgren S.M., Skipper C.P., Nicol M.R., Pullen M.F., Rajasingham R., McDonald E.G., Lee T.C., et al. Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19) Open Forum Infect. Dis. 2020;7:130. doi: 10.1093/ofid/ofaa130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa130</ArticleId><ArticleId IdType="pmc">PMC7184359</ArticleId><ArticleId IdType="pubmed">32363212</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallotto C., Suardi L.R., Gabbuti A., Esperti S., Mecocci L., Blanc P. Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19) J. Med Virol. 2021;93:2631&#x2013;2634. doi: 10.1002/jmv.26898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26898</ArticleId><ArticleId IdType="pmc">PMC8013491</ArticleId><ArticleId IdType="pubmed">33620107</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.-I., Postema P.G., Arbelo E., Behr E.R., Bezzina C.R., Napolitano C., Robyns T., Probst V., Schulze-Bahr E., Remme C.A., et al. SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes. Heart Rhythm. 2020;17:1456&#x2013;1462. doi: 10.1016/j.hrthm.2020.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.03.024</ArticleId><ArticleId IdType="pmc">PMC7156157</ArticleId><ArticleId IdType="pubmed">32244059</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley L.F., Cheng J.W.M., Desai A. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin Converting Enzyme 2. J. Cardiovasc. Pharmacol. 2020;75:526&#x2013;529. doi: 10.1097/FJC.0000000000000840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0000000000000840</ArticleId><ArticleId IdType="pmc">PMC7219856</ArticleId><ArticleId IdType="pubmed">32301766</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippisley-Cox J., Young D., Coupland C., Channon K.M., Tan P.S., Harrison D.A., Rowan K., Aveyard P., Pavord I.D., Watkinson P.J. Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: Cohort study including 8.3 million people. Heart. 2020;106:1503&#x2013;1511. doi: 10.1136/heartjnl-2020-317393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-317393</ArticleId><ArticleId IdType="pmc">PMC7509391</ArticleId><ArticleId IdType="pubmed">32737124</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli B., Madhavan M.V., Jimenez D., Chuich T., Dreyfus I., Driggin E., Der Nigoghossian C., Ageno W., Madjid M., Guo Y., et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 2020;75:2950&#x2013;2973. doi: 10.1016/j.jacc.2020.04.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.04.031</ArticleId><ArticleId IdType="pmc">PMC7164881</ArticleId><ArticleId IdType="pubmed">32311448</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai Z., Li C., Chen Y., Gerotziafas G., Zhang Z., Wan J., Liu P., Elalamy I., Wang C. Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines. Thromb. Haemost. 2020;120:937&#x2013;948. doi: 10.1055/s-0040-1710019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1710019</ArticleId><ArticleId IdType="pmc">PMC7295267</ArticleId><ArticleId IdType="pubmed">32316065</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson R.A., Johnson D.M., Dharia R.N., Merli G.J., Doherty J.U. Anti-coagulant and anti-platelet therapy in the COVID-19 patient: A best practices quality initiative across a large health system. Hosp. Pract. 2020;48:169&#x2013;179. doi: 10.1080/21548331.2020.1772639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21548331.2020.1772639</ArticleId><ArticleId IdType="pmc">PMC7441801</ArticleId><ArticleId IdType="pubmed">32429774</ArticleId></ArticleIdList></Reference><Reference><Citation>Gawa&#x142;ko M., Kap&#x142;on-Cie&#x15b;licka A., Hohl M., Dobrev D., Linz D. COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications. Int. J. Cardiol. Heart Vasc. 2020;30:100631. doi: 10.1016/j.ijcha.2020.100631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2020.100631</ArticleId><ArticleId IdType="pmc">PMC7462635</ArticleId><ArticleId IdType="pubmed">32904969</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID&#x2014;The Lancet Respiratory Medicine. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence  COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19.  [(accessed on 28 January 2021)];2020  Available online:  https://www.nice.org.uk/guidance/ng188/chapter/context#post-covid-19-syndrome.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health Research  Living with Covid-19.  [(accessed on 28 January 2021)];2020  Available online:  https://evidence.nihr.ac.uk/themedreview/living-with-covid19/</Citation></Reference><Reference><Citation>Yelin D., Margalit I., Yahav D., Runold M., Bruchfeld J. Long COVID-19&#x2014;It&#x2019;s not over until? Clin. Microbiol. Infect. 2020;27:506&#x2013;508. doi: 10.1016/j.cmi.2020.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.12.001</ArticleId><ArticleId IdType="pmc">PMC7832095</ArticleId><ArticleId IdType="pubmed">33316400</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M.S., Kristiansen M.F., Hanusson K.D., Danielsen M.E., Steig B.A., Gaini S., Str&#xf8;m M., Weihe P. Long COVID in the Faroe Islands&#x2014;A longitudinal study among non-hospitalized patients. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa1792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartoretti E., Sartoretti T., Imoberdorf R., Drackl&#xe9; J., Sartoretti-Schefer S. Long-segment arterial cerebral vessel thrombosis after mild COVID-19. BMJ Case Rep. 2020;13:e236571. doi: 10.1136/bcr-2020-236571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-236571</ArticleId><ArticleId IdType="pmc">PMC7497138</ArticleId><ArticleId IdType="pubmed">32938654</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M., Ciccarelli M., Cecconi M., Aghemo A., Morelli P., Gelardi F., Chiti A. Vasculitis changes in COVID-19 survivors with persistent symptoms: An [18F]FDG-PET/CT study. Eur. J. Nucl. Med. Mol. Imaging. 2020;48:1460&#x2013;1466. doi: 10.1007/s00259-020-05084-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05084-3</ArticleId><ArticleId IdType="pmc">PMC7595761</ArticleId><ArticleId IdType="pubmed">33123760</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagia P., Ojha V., Naik N., Sharma S. Myocardial fibrosis detected by cardiovascular magnetic resonance in absence of myocardial oedema in a patient recovered from COVID-19. BMJ Case Rep. 2020;13:e240193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10577794</ArticleId><ArticleId IdType="pubmed">33334776</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S., Al H.H., Agarwal S.K., Albastaki U. Possible association between myocardial infarction with nonobstructed coronary arteries and SARS-CoV-2 infection. CMAJ Can. Med Assoc. J. 2020;192:E1633&#x2013;E1636. doi: 10.1503/cmaj.202106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.202106</ArticleId><ArticleId IdType="pmc">PMC7721399</ArticleId><ArticleId IdType="pubmed">33257327</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Zhao P., Tang D., Zhu T., Han R., Zhan C., Liu W., Zeng H., Tao Q., Xia L. Cardiac Involvement in Patients Recovered from COVID-2019 Identified Using Magnetic Resonance Imaging. JACC Cardiovasc. Imaging. 2020;13:2330&#x2013;2339. doi: 10.1016/j.jcmg.2020.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.05.004</ArticleId><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T., Knight D.S., Razvi Y., Kumar K., Vimalesvaran K., Thornton G., Patel R., Chacko L., Brown J.T., Coyle C., et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur. Heart J. 2021;42:1866&#x2013;1878. doi: 10.1093/eurheartj/ehab075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab075</ArticleId><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz N.H., S&#xf8;rvoll I.H., Michelsen A.E., Munthe L.A., Lund-Johansen F., Ahlen M.T., Wiedmann M., Aamodt A.-H., Skatt&#xf8;r T.H., Tj&#xf8;nnfjord G.E., et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N. Engl. J. Med. 2021;384:2124&#x2013;2130. doi: 10.1056/NEJMoa2104882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2104882</ArticleId><ArticleId IdType="pmc">PMC8112568</ArticleId><ArticleId IdType="pubmed">33835768</ArticleId></ArticleIdList></Reference><Reference><Citation>Greinacher A., Thiele T., Warkentin T.E., Weisser K., Kyrle P.A., Eichinger S. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N. Engl. J. Med. 2021;384:2092&#x2013;2101. doi: 10.1056/NEJMoa2104840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2104840</ArticleId><ArticleId IdType="pmc">PMC8095372</ArticleId><ArticleId IdType="pubmed">33835769</ArticleId></ArticleIdList></Reference><Reference><Citation>See I., Su J.R., Lale A., Woo E.J., Guh A.Y., Shimabukuro T.T., Streiff M.B., Rao A.K., Wheeler A.P., Beavers S.F., et al. US Case Reports of Cerebral Venous Sinus Thrombosis with Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021. JAMA. 2021;325:2448&#x2013;2456. doi: 10.1001/jama.2021.7517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.7517</ArticleId><ArticleId IdType="pmc">PMC8087975</ArticleId><ArticleId IdType="pubmed">33929487</ArticleId></ArticleIdList></Reference><Reference><Citation>Agyeman A.A., Chin K.L., Landersdorfer C.B., Liew D., Ofori-Asenso R. Smell and Taste Dysfunction in Patients with COVID-19: A Systematic Review and Meta-analysis. Mayo Clin. Proc. 2020;95:1621&#x2013;1631. doi: 10.1016/j.mayocp.2020.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.05.030</ArticleId><ArticleId IdType="pmc">PMC7275152</ArticleId><ArticleId IdType="pubmed">32753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020;382:1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M., Dirksen A., Taraborrelli P., Torocastro M., Panagopoulos D., Sutton R., Lim P.B. Autonomic dysfunction in &#x2018;long COVID&#x2019;: Rationale, physiology and management strategies. Clin. Med. 2020;21:e63&#x2013;e67. doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>